CELLVIE

Serial Number 79288683
602

Registration Progress

Application Filed
Feb 26, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: CELLVIE
Previous Owner: cellvie Inc.
Classes: 005, 010, 042, 044

Trademark Image

CELLVIE

Basic Information

Serial Number
79288683
Filing Date
February 26, 2020
Abandonment Date
December 7, 2021
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 17, 2021
Classes
005 010 042 044

Rights Holder

cellvie Inc.

98
Address
4326B Scotland Street
Houston TX 77007
US

Ownership History

Cellvie UG (haftungsbeschränkt)

Original Applicant
16
DE

cellvie Inc.

New Owner Before Publication #1
98
US

Legal Representation

Attorney
Bruce Londa

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

25 events
Date Code Type Description Documents
Sep 20, 2024 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Jan 9, 2023 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 19, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 17, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 25, 2021 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Dec 17, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Dec 17, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 8, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 8, 2021 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jun 5, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 5, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 5, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 29, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 29, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 26, 2021 ALIE A ASSIGNED TO LIE Loading...
Dec 22, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 27, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 5, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 25, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 16, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 15, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 14, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 9, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 9, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 2, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Preparations for medical purposes employing mitochondria; cardiovascular treatment preparations employing mitochondria; cardiovascular pharmaceuticals employing mitochondria used in treating arrhythmias; pharmaceutical and biological preparations for the treatment of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies, tumors or diabetes mitochondria for transplant purposes for medical use; pharmaceutical and biological preparations for the application of mitochondria transplantation for medical purposes in vessel and organ transplantations; implantable living tissue and mitochondria for the promotion of tissue growth, for medical use; mitochondria, for medical use; biological tissue cultures containing mitochondria for medical purposes; pharmaceutical and biological preparations containing mitochondria for tissue regeneration and protection for medical purposes; living cell components, namely, mitochondria, including genetically-modified mitochondria or pharmaceutically treated mitochondria, for medical use in humans and veterinary use in animals
Class 010
Prosthetic tissues based on mitochondria for parietal, vascular and visceral use; medical apparatus and devices for the processing of tissue- or cell-samples for the isolation of mitochondria or other cell components, namely, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from muscle tissue or other human or animal tissues, as well as from cells and cell cultures; filter for the isolation of cell components, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from cells for medical purposes; medical apparatus and devices for the transplantation or injection of cells or cell component, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles in humans or animals
Class 042
Scientific and technological services, namely, scientific and clinical research, analysis and testing in the field of mitochondrial isolation or transplantation; scientific and clinical research and development services in the field of mitochondria; conducting clinical trials for others in the field of cardiovascular diseases, ischemia-and reperfusion-injuries, heart transplantations, tumor treatments, mitochondrial myopathies analysis of human tissues for scientific and clinical research relating to mitochondria; scientific and clinical research, analysis and testing services relating to the isolation and cultivation of human and animal mitochondria
Class 044
Medical testing services for diagnostic and disease treatment purposes relating to cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of human or animal tissues for mitochondria transplant treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of cells and cell components in relation to mitochondria for diagnostic and treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors

Additional Information

Design Mark
The mark consists of multiple blue dots, being light blue in the middle and getting progressively darker toward the outside, some connected with curved lines, forming a spiral shape. The word "CELLVIE" sits underneath the spiral in grey.
Color Claim
The color(s) blue, light blue and grey is/are claimed as a feature of the mark.

Classification

International Classes
005 010 042 044